A detailed history of Stablepoint Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stablepoint Partners, LLC holds 3,339 shares of LLY stock, worth $2.56 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
3,339
Previous 3,486 4.22%
Holding current value
$2.56 Million
Previous $2.82 Billion 5.05%
% of portfolio
0.54%
Previous 0.55%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$772.14 - $960.02 $113,504 - $141,122
-147 Reduced 4.22%
3,339 $2.96 Billion
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $36,968 - $46,361
-51 Reduced 1.44%
3,486 $2.82 Billion
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $461,323 - $617,186
779 Added 28.25%
3,537 $2.75 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $1.45 Million - $1.71 Million
2,758 New
2,758 $1.61 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stablepoint Partners, LLC Portfolio

Follow Stablepoint Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stablepoint Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stablepoint Partners, LLC with notifications on news.